Mon, 08 Jan 2018 07:27:35 GMT
Novo Nordisk seeks to acquire Ablynx for around €2.6B
On December 22, the Danish pharmaceuticals maker Novo Nordisk offered to acquire Belgium's biopharma company Ablynx for €28.00 per share, which is about €2.6B in total.